Stimulation of ANP secretion by 2-Cl-IB-MECA through A(3) receptor and CaMKII

Adenosine is a potent mediator of myocardial protection against hypertrophy via A(1) or A(3) receptors that may be partly related to atrial natriuretic peptide (ANP) release. However, little is known about the possible involvement of the A(3) receptor on ANP release. We studied the effects of the A(3) receptor on atrial functions and its modification in hypertrophied atria. A selective A(3) receptor agonist, 2-chloro-N-6-(3-iodobenzyl) adenosine-S'-N-methyluronamide (2-Cl-IB-MECA), was perfused into isolated, beating rat atria with and without receptor modifiers. 2-Cl-IB-MECA dose-dependently increased the ANP secretion, which was blocked by the A(3) receptor antagonist, but the increased atrial contractility and decreased cAMP levels induced by 30 mu M 2-Cl-IB-MECA were not affected. The 100 mu M 2-(1-hexylnyl)-N-methyladenosine (HEMADO) and N-6-(3-iodobenzyl) adenosine-5'-N-methyluronamide (IB-MECA), A(3) receptor agonist, also stimulated the ANP secretion without positive inotropy. The potency for the stimulation of ANP secretion was 2-Cl-IB-MECA >> IB-MECA = HEMADO. The inhibition of the ryanodine receptor or calcium/calmodulin-dependent kinase II (CaM-KII) attenuated 2-Cl-IB-MECA-induced ANP release, positive inotropy, and translocation of extracellular fluid. However, the inhibition of L-type Ca2+ channels, sarcoplasmic reticulum Ca2+-reuptake, phospholipase C or inositol 1,4,5-triphosphate receptors did not affect these parameters. 2-Cl-IB-MECA decreased cAMP level, which was blocked only with an inhibitor of CaMKII or adenylyl cyclase. These results suggest that 2-Cl-IB-MECA increases the ANP secretion mainly via A(3) receptor activation and positive inotropy by intracellular Ca2+ regulation via the ryanodine receptor and CaMKII. (c) 2008 Elsevier Inc. All rights reserved.